Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 1 1

Status

Completed 22Recruiting 5Unknown 4Active not recruiting 3Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Dermatologic 4Breast 3Other hematologic neoplasm 1Lymphoid 1CNS 1

Conditions

Melanoma 312Carcinoma, Basal Cell 60Skin Neoplasms 52Lymphoma, T-Cell, Cutaneous 37Breast Neoplasms 31Uveal Melanoma 29Neoplasms 27Lung Neoplasms 27Carcinoma, Non-Small-Cell Lung 27Keratosis, Actinic 25Neoplasm Metastasis 24Carcinoma, Squamous Cell 22Carcinoma, Renal Cell 21Lymphoma 17Mycosis Fungoides 16Lymphoma, Large B-Cell, Diffuse 15Hodgkin Disease 15Urinary Bladder Neoplasms 14Sezary Syndrome 14Pancreatic Neoplasms 14Lymphoma, Non-Hodgkin 14Lymphoma, Follicular 14Leukemia, Lymphocytic, Chronic, B-Cell 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Ovarian Neoplasms 13Lymphoma, Mantle-Cell 13Lymphoma, B-Cell, Marginal Zone 13Colorectal Neoplasms 13Burkitt Lymphoma 13Lymphoma, Large-Cell, Immunoblastic 12

Interventions

methyl 5-aminolevulinate 1Photochemotherapy 1Floderm topical cream 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Skin Diseases × Dermatologic × Clear all
NCT05463523 2022-12-21

A Multi-centric Clinical Trial in China for Skin Diseases Intelligent Diagnosis and Treatment System

Xiangya Hospital of Central South University

Unknown
200 enrolled
Dermatologic

Skin Diseases, Skin Neoplasms

NCT05488860 2022-08-05

Piezoelectric Drived Microneedling in Treating Refractory Skin Diseases

Xiangya Hospital of Central South University

Phase NA Unknown
20 enrolled
Dermatologic

Keloid, Skin Diseases, Skin Neoplasms, Warts, Cicatrix, Hypertrophic

NCT04138342 2019-10-24

Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer

Al-Azhar University

Phase 1 Unknown
30 enrolled
BreastDermatologic

Breast Neoplasms, Skin Diseases, Skin Neoplasms

NCT01491711 2014-01-31

Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate

Maastricht University Medical Center

Phase 4 Unknown
162 enrolled
Dermatologic

Carcinoma, Basal Cell, Connective Tissue Diseases, Skin Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡